Trial Details
RECRUITINGBasic Information
| Clinical ID | c240 |
|---|---|
| Identifier | NCT05428345 |
| Trial Title | A Study of Vedolizumab SC Given to Adults With Moderate to Severe Ulcerative Colitis or Crohn's Disease in South Korea |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis|Crohn's Disease|Inflammatory Bowel Disease (IBD) |
| Interventions | - |
Participant Information
| Sponsor | Takeda |
|---|---|
| City | Goyang-si |
| Country/Region | Korea, Republic of |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | OBSERVATIONAL |
|---|---|
| Phase | - |
Time Information
| Start Date | 2023-09-25 |
|---|---|
| Primary Completion Date | 2027-11-30 |
| Completion Date | 2027-11-30 |